Free Trial
NASDAQ:BGLC

BioNexus Gene Lab (BGLC) Stock Price, News & Analysis

$0.35 +0.01 (+2.72%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$0.35 +0.00 (+0.77%)
As of 02/21/2025 06:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About BioNexus Gene Lab Stock (NASDAQ:BGLC)

Key Stats

Today's Range
$0.34
$0.36
50-Day Range
$0.23
$0.46
52-Week Range
$0.21
$1.20
Volume
37,257 shs
Average Volume
177,340 shs
Market Capitalization
$6.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers. Its products are used to produce handrails, bench tops, automotive and aero parts, and paneling for hospital, laboratory, industrial clean rooms, and covers for various instruments used in manufacturing. The company also involves in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers to detect potential risk of diseases. It markets its products through its website, warehouse, marketing personnel, and suppliers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

Receive BGLC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioNexus Gene Lab and its competitors with MarketBeat's FREE daily newsletter.

BGLC Stock News Headlines

BioNexus Gene Lab Leads Our Top 3 US Penny Stocks
BioNexus Gene Lab Faces Delisting and Leadership Changes
The Real Hillbilly Elegy
The mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky, Tennessee and beyond… It's one of our country’s most scenic areas. But hidden beneath the beauty is an ugly reality: our most beautiful land is also the poorest. It’s a tragedy because for over 200 years, generation after generation has worked “coal country” with nothing but a pick and shovel, hauling billions of dollars from the ground.
BioNexus partners with Vitarray for gene detection
European Central Bank cuts key interest rates as inflation falls
See More Headlines

BGLC Stock Analysis - Frequently Asked Questions

BioNexus Gene Lab's stock was trading at $0.2797 at the beginning of 2025. Since then, BGLC stock has increased by 25.6% and is now trading at $0.3513.
View the best growth stocks for 2025 here
.

BioNexus Gene Lab (BGLC) raised $5 million in an initial public offering on Thursday, July 20th 2023. The company issued 1,300,000 shares at $4.00 per share. Network 1 Financial Securities served as the underwriter for the IPO.

Shares of BGLC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that BioNexus Gene Lab investors own include Sangamo Therapeutics (SGMO), NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Adobe (ADBE), Arista Networks (ANET) and e.l.f. Beauty (ELF).

Company Calendar

Today
2/22/2025
Next Earnings (Estimated)
4/15/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Medical laboratories
Sub-Industry
Healthcare
Current Symbol
NASDAQ:BGLC
Fax
N/A
Employees
30
Year Founded
N/A

Profitability

Net Income
$-2,630,000.00
Pretax Margin
-9.93%

Debt

Sales & Book Value

Annual Sales
$9.77 million
Book Value
$0.55 per share

Miscellaneous

Free Float
17,605,000
Market Cap
$6.31 million
Optionable
Not Optionable
Beta
5.79
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NASDAQ:BGLC) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners